Psychopharmacology for counselors: what to recognize and when to refer
Home / Guides / Clinical guides for NCMHCE-style cases
Short answer. Counselors do not prescribe, but exam cases expect you to recognize the main medication classes (SSRIs, SNRIs, tricyclics, MAOIs, mood stabilizers, antipsychotics, benzodiazepines, stimulants and medications for substance use disorders), spot dangerous side effects such as serotonin syndrome, lithium toxicity and tardive dyskinesia, and know that antidepressants carry a boxed warning about suicidal thinking in children, adolescents and young adults. The counselor's move is to consult and refer, never to change a dose.
Source: Mental Health Medications (checked 2026-11-14); Pamelor (nortriptyline) prescribing information, 2007, boxed warning "Suicidality and Antidepressant Drugs" (checked 2026-11-14).
What is the counselor's role with medication?
Recognize, educate in general terms, monitor and refer; prescribing and dose changes belong to a prescriber. The NCMHCE outline has no medication domain, but its tasks include "Refer to others for concurrent treatment" and "Collaborate with other providers and client support systems" (source: NCMHCE Content Outline, checked 2026-11-14). In a case, medication shows up as a client who stopped a drug, describes a side effect, or needs a referral.
When a client reports a side effect or wants to stop a medication, the answer is almost always: encourage them not to stop on their own, and help them contact the prescriber. NIMH makes the same point about antipsychotics, advising people to check with a provider before stopping (source: NIMH mental health medications, checked 2026-11-14).
Which medication classes should counselors recognize?
NIMH groups mental health medications into antidepressants, anti-anxiety medications, stimulants, antipsychotics and mood stabilizers (source: NIMH mental health medications, checked 2026-11-14). The table adds common examples and the risks exam items mention (source: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press).
| Class | Examples | Used for | Risks to recognize |
|---|---|---|---|
| SSRIs | Fluoxetine, sertraline, escitalopram, paroxetine | Depression, anxiety disorders, OCD | Weeks to full effect; GI upset, sexual side effects; serotonin syndrome in combinations; boxed warning in young people |
| SNRIs | Venlafaxine, duloxetine | Depression, anxiety, some pain conditions | Similar to SSRIs; discontinuation symptoms if stopped abruptly |
| NDRI | Bupropion | Depression, smoking cessation | Lowers seizure threshold; fewer sexual side effects |
| Tricyclics (TCAs) | Amitriptyline, nortriptyline, imipramine | Depression, some pain conditions | Sedation, dry mouth, constipation; dangerous in overdose because of heart effects |
| MAOIs | Phenelzine, tranylcypromine | Depression when others fail | Hypertensive crisis with tyramine-rich foods and many drug interactions |
| Mood stabilizers | Lithium; valproate, lamotrigine, carbamazepine | Bipolar disorder | Lithium: narrow safe range, blood level monitoring; lamotrigine: serious rash |
| Antipsychotics, first generation (typical) | Haloperidol, chlorpromazine | Psychosis, mania | Movement side effects, tardive dyskinesia, NMS |
| Antipsychotics, second generation (atypical) | Risperidone, olanzapine, quetiapine, aripiprazole, clozapine | Psychosis, bipolar disorder, add-on for depression | Weight gain and metabolic effects; clozapine requires blood count monitoring |
| Benzodiazepines | Alprazolam, lorazepam, clonazepam, diazepam | Short-term anxiety, panic, alcohol withdrawal management | Sedation, dependence, dangerous with alcohol or opioids, withdrawal seizures if stopped abruptly |
| Other anxiolytics | Buspirone; beta-blockers such as propranolol | GAD; physical symptoms of performance anxiety | Buspirone takes weeks; not habit forming |
| Stimulants | Methylphenidate, amphetamine salts | ADHD | Appetite loss, insomnia, misuse potential (Schedule II) |
What is the antidepressant boxed warning?
All antidepressants carry an FDA boxed warning about suicidality in young people. The labeling states that antidepressants increased the risk of suicidal thinking and behavior compared with placebo "in children, adolescents, and young adults" in short-term studies, that short-term studies did not show an increased risk in adults beyond age 24, and that there was a reduction in risk in adults 65 and older (source: FDA-approved antidepressant label, boxed warning, checked 2026-11-14). It tells prescribers to monitor patients of all ages for worsening, suicidality and unusual changes in behavior, and to advise families to watch closely (source: FDA-approved antidepressant label, boxed warning, checked 2026-11-14). NIMH describes the same risk as applying to people under 25, especially early in treatment or after a dose change (source: NIMH mental health medications, checked 2026-11-14).
For a counselor, the practical meaning is closer monitoring in the first weeks of a new antidepressant or dose change for a client under 25, and asking about suicidal thoughts at each session. See suicide risk assessment.
What is serotonin syndrome?
Serotonin syndrome is a rare but life-threatening reaction when serotonin-acting drugs are combined, such as an antidepressant with a triptan migraine drug or St. John's wort (source: NIMH mental health medications, checked 2026-11-14). NIMH lists agitation, muscle twitches, hallucinations, high temperature and unusual blood pressure changes among the symptoms. A client who mentions starting an herbal supplement or a new migraine drug while on an SSRI and now feels agitated and feverish needs urgent medical care.
Why is lithium monitored so closely?
Lithium works in a narrow range between an effective level and a toxic one, so prescribers check blood levels along with kidney and thyroid function (source: NIMH mental health medications; Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press, checked 2026-11-14). Dehydration, heavy sweating, vomiting or diarrhea, and some common drugs such as certain anti-inflammatory pain relievers can push levels up. Early toxicity can look like worsening tremor, nausea, diarrhea, unsteadiness and confusion. A client on lithium who describes these, or who just started a new diet or medication, needs to contact the prescriber the same day.
Which antipsychotic side effects should you recognize?
Movement side effects, metabolic changes and NMS. NIMH notes that long-term use of typical antipsychotics can cause uncontrollable muscle movements (tardive dyskinesia), and that antipsychotics carry a boxed warning about increased stroke and death in older adults with dementia (source: NIMH mental health medications, checked 2026-11-14). Tardive dyskinesia shows up as repetitive movements of the mouth, tongue and face that may persist. Acute effects include muscle stiffness, tremor and akathisia, an inner restlessness that can be mistaken for anxiety. Neuroleptic malignant syndrome (high fever, severe muscle rigidity, confusion and unstable vital signs) is a medical emergency (source: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press). Second-generation drugs carry more risk of weight gain and metabolic problems, which matter for treatment adherence and self-esteem.
What should counselors know about benzodiazepines?
Benzodiazepines act fast and are usually prescribed for short periods, and providers taper them slowly to reduce the likelihood of withdrawal (source: NIMH mental health medications, checked 2026-11-14). Long-term use can lead to tolerance and dependence. Combined with alcohol or opioids they can suppress breathing (source: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press). Abrupt stopping after regular use can cause seizures, so a client who wants to quit needs the prescriber's help. Buspirone is the non-benzodiazepine option for GAD that does not cause dependence but takes weeks to work.
Which medications treat substance use disorders?
For opioid use disorder, FDA lists methadone (agonist), buprenorphine (partial agonist) and extended-release naltrexone (antagonist) (source: FDA medications for opioid use disorder, checked 2026-11-14). For alcohol use disorder, NIAAA lists naltrexone (reduces the urge to drink), acamprosate (eases the negative feelings of early abstinence) and disulfiram (causes unpleasant symptoms if alcohol is consumed), all nonaddictive (source: NIAAA treatment guide, checked 2026-11-14). A common exam trap is treating medication for opioid use disorder as "substituting one addiction for another"; it is an evidence-based treatment that counseling should support. Diagnosis and level of care are on substance use disorders.
What should you ask about medication at intake?
Ask what the client takes, who prescribes it, how they actually take it and what they notice. A short checklist covers most of it:
- Current prescriptions, over-the-counter drugs and supplements, including herbal products.
- Who prescribes each one, and whether you may coordinate with them (get written consent).
- Whether doses are skipped or changed, and why: cost, side effects, stigma or feeling better.
- Side effects the client has noticed, such as sleep, appetite, weight, sexual function or restlessness.
- Alcohol and drug use, which interacts with many of the classes above (source: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press).
Nonadherence is common and is a counseling topic in its own right. Exploring the client's reasons with curiosity, in the motivational interviewing style, fits the outline task of educating the client about the value of treatment plan compliance (source: NCMHCE Content Outline, checked 2026-11-14).
Worked example: a medication problem in session
A 19-year-old college student started sertraline three weeks ago, prescribed by campus health for depression. She tells you she feels "jittery and weird", has had more thoughts about not wanting to be alive this week, and plans to stop the pill tomorrow. She also started taking St. John's wort because a friend said it helps.
- Safety first. New or increased suicidal thoughts at age 19, early in antidepressant treatment, fall squarely within the boxed warning population (source: FDA-approved antidepressant label, boxed warning, checked 2026-11-14). Complete a suicide risk assessment now.
- Recognize the interaction. An SSRI plus St. John's wort is a serotonin syndrome combination (source: NIMH mental health medications, checked 2026-11-14). Ask about fever, muscle twitching, confusion or a racing heart; if present, this is a medical emergency.
- Stay in scope. Do not tell her to stop or continue either product. Encourage her not to change anything on her own and help her contact the prescriber today, with her consent to share what she told you.
- Document and follow up. Record the report, the risk assessment, the referral and a check-in within days.
That sequence (assess risk, recognize the medical issue, refer to the prescriber, document) is the pattern most medication items reward. It also connects to diagnosis: a client whose mood lifts into sleeplessness and racing thoughts on an antidepressant may need reassessment for bipolar disorder, covered on DSM-5-TR diagnosis.
Frequently asked questions
Can a counselor recommend a dose change?
No. Dose decisions belong to the prescriber. The counselor encourages the client to talk with the prescriber and, with consent, coordinates care.
Which age group does the antidepressant boxed warning cover?
Children, adolescents and young adults; the labeling says short-term studies did not show increased risk in adults beyond age 24 (source: FDA-approved antidepressant label, boxed warning, checked 2026-11-14).
What should I do if a client on an SSRI reports fever, agitation and muscle twitching?
Treat it as possible serotonin syndrome and get urgent medical care (source: NIMH mental health medications, checked 2026-11-14).
Why do lithium levels need blood tests?
The effective and toxic levels are close together, so prescribers monitor lithium levels and kidney and thyroid function (source: NIMH mental health medications, checked 2026-11-14).
Check yourself: 7 practice questions
Original questions written for this page. Pick your answer, then open it to check.
- Scope of practice
A client says her antidepressant makes her feel numb and she wants your advice on lowering the dose. What is the best response?
- Suggest halving the dose for a week
- Tell her to stop it and see if she feels better
- Explore the side effect and help her bring it to her prescriber
- Say medication is not something counseling addresses
Show answer
Answer: C. Counselors explore and refer; dose changes belong to the prescriber. Refusing to discuss medication misses side effects that affect treatment.
- Boxed warning
The FDA boxed warning on antidepressants concerns increased suicidal thinking and behavior in which group?
- Adults 65 and older
- Children, adolescents and young adults
- Pregnant women
- Adults 25 to 64
Show answer
Answer: B. The warning covers children, adolescents and young adults. In adults 65 and older the labeling reports a reduction in risk compared with placebo.
- Serotonin syndrome
A client on fluoxetine started St. John's wort and now has agitation, fever and muscle twitching. What is most likely?
- Serotonin syndrome
- Tardive dyskinesia
- Lithium toxicity
- Panic attack
Show answer
Answer: A. Combining serotonin-acting products with these symptoms suggests serotonin syndrome, a medical emergency. A panic attack does not explain the fever.
- Antipsychotics
After years on haloperidol, a client has repetitive lip smacking and tongue movements. Which side effect is this?
- Akathisia
- Neuroleptic malignant syndrome
- Serotonin syndrome
- Tardive dyskinesia
Show answer
Answer: D. Late-onset repetitive movements of the mouth and face after long-term typical antipsychotic use are tardive dyskinesia. Akathisia is an inner restlessness, usually early in treatment.
- MAOIs
Which medication class requires dietary restrictions on tyramine-rich foods such as aged cheese?
- SSRIs
- Benzodiazepines
- MAOIs
- Stimulants
Show answer
Answer: C. MAOIs can cause a hypertensive crisis with tyramine-rich foods. SSRIs do not carry this restriction.
- Benzodiazepines
A client who has taken alprazolam daily for two years says he will quit "cold turkey" this weekend. What is the main concern?
- Withdrawal that can include seizures, so stopping should be planned with the prescriber
- Weight gain
- Tardive dyskinesia
- Serotonin syndrome
Show answer
Answer: A. Abrupt benzodiazepine withdrawal after long-term use can cause seizures, so providers taper slowly. The other options are side effects of different drug classes.
- MAT
Which medication for opioid use disorder is an opioid antagonist?
- Methadone
- Naltrexone
- Buprenorphine
- Acamprosate
Show answer
Answer: B. Extended-release naltrexone is the antagonist. Methadone is a full agonist and buprenorphine a partial agonist; acamprosate is for alcohol use disorder.
The Intakewise app has original NCE-style questions in all eight core areas and 30 NCMHCE-style clinical sessions you walk from intake to treatment.
Get it onGoogle Play Practice free first
iPhone app coming soon. Until then, the free practice works in any phone browser.
Sources
- NCMHCE Content Outline (revised October 8, 2025), NBCC. Checked 2026-11-14.
- Mental Health Medications, National Institute of Mental Health. Checked 2026-11-14.
- Pamelor (nortriptyline) prescribing information, 2007, boxed warning "Suicidality and Antidepressant Drugs", U.S. Food and Drug Administration (Drugs@FDA). Checked 2026-11-14.
- Medications for Opioid Use Disorder, U.S. Food and Drug Administration. Checked 2026-11-14.
- Treatment for Alcohol Problems: Finding and Getting Help, National Institute on Alcohol Abuse and Alcoholism. Checked 2026-11-14.
- Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press. Reference work cited by title.
Exam formats and licensing rules change. Confirm details with NBCC, CCE and your state board.
How this page was made: The NIMH medications page, an FDA-approved antidepressant label with the boxed warning, the FDA opioid use disorder medication page, the NIAAA treatment guide and the NCMHCE Content Outline were opened on 2026-11-14; examples and side effect detail follow standard psychopharmacology references; the vignette and quiz are Intakewise's own.